India does not face a nationwide anti-rabies vaccine shortage, the Union Government told the Lok Sabha on 24 July 2026. Yet patients in Delhi, Bhopal, Sonipat and other cities have struggled to find anti-rabies vaccine (ARV) or rabies immunoglobulin (RIG) at particular public hospitals. Both can be true because procurement and distribution are decentralised, leaving facilities exposed to tender delays, sudden demand and weak stock movement.
Rabies is preventable when post-exposure treatment begins promptly, but almost always fatal after symptoms appear. Local availability decides whether a bite victim receives care without being sent elsewhere.
Key Highlights
- The Centre says it has received no report showing a countrywide ARV shortage.
- States and Union Territories procure and distribute ARV and RIG through decentralised systems.
- Delhi reportedly had 1.27 lakh vaccine vials awaiting delivery because warehouse cold storage was unavailable.
- Bhopal’s JP Hospital held 748 ARV vials against a monthly need of nearly 2,500 in April.
- A national survey found ARV in nearly four-fifths of public facilities, but RIG in one-fifth.
What Did The Government Tell The Lok Sabha?
Health Minister JP Nadda’s Lok Sabha reply said the Centre had not received reports of any nationwide anti-rabies vaccine shortage. It acknowledged temporary gaps caused by increased demand, procurement delays or supply-chain problems. States can respond through stock redistribution, emergency purchases and stronger logistics.
The Centre supports states through the National Health Mission and National Free Drug Initiative, but ARV and RIG purchasing remains decentralised. The National Rabies Control Programme funds vaccines, immunoglobulin, anti-rabies clinics, wound-washing facilities, laboratories, training and surveillance. The government also said national data on all ARV recipients and state-wise rabies deaths are not maintained centrally.
Why Are Local Anti-Rabies Vaccine Complaints Increasing?
Gaps can occur after procurement succeeds, but stock does not reach patients. In Delhi, 1.27 lakh ARV vials were reportedly awaiting delivery in June because the state warehouse lacked cold-storage space. That points to distribution trouble, not nationwide manufacturing failure.
Bhopal showed another pressure point. JP Hospital had 748 vaccine vials and 49 equine RIG doses in April, against a monthly ARV requirement of about 2,500 vials. Stock was expected to last only 10–12 days. Bhopal records roughly 20,000 dog-bite cases annually, so even a brief interruption becomes highly visible.
In Sonipat, the National Human Rights Commission recorded allegations that a civil hospital lacked vaccine and serum when a 44-year-old bite victim sought care. The NHRC issued notices after his reported death. Such incidents fuel distrust even when supplies exist elsewhere.
An ICMR-led national survey offers wider context: nearly four-fifths of public facilities had ARV, while only one-fifth had RIG. Availability varied by region and care level. A national average may look reassuring while a specific primary centre still faces a stock-out.
What Should Patients Do After An Animal Bite?
Wash the wound immediately with soap and running water for about 15 minutes, apply antiseptic, and seek medical care without waiting for symptoms. A doctor will classify the exposure and decide whether ARV alone or ARV with RIG is needed. The WHO rabies guidance says dog bites and scratches cause 99% of human rabies cases globally.
Do not abandon treatment because one hospital lacks stock. The government portal lists a 15400 helpline for first-aid advice and nearby facilities reporting ARV or serum availability. The official Centre for One Health, NCDC, also said in an X post that rabies is fatal yet preventable through dog vaccination, awareness and timely post-exposure care.
Can India Close The Local Supply Gap Before 2030?
India aims to eliminate dog-mediated human rabies deaths by 2030. States need live facility-level stock dashboards, minimum buffers, faster emergency purchasing, working cold chains and clear RIG referral routes. Bite surveillance must connect hospitals, municipal bodies and animal-husbandry teams.
The dispute is not simply “shortage versus no shortage”. It is a last-mile access problem. National stocks offer little comfort when a patient reaches a clinic with no dose, no serum or no reliable referral information.
Frequently Asked Questions
1. Is India facing a nationwide anti-rabies vaccine shortage?
No. The Centre says problems are temporary, localised and linked to procurement or distribution failures.
2. Why is rabies immunoglobulin harder to find than ARV?
RIG availability is lower because it requires specialised procurement, storage, administration and facility-level demand planning.
3. Can treatment wait if the bite looks small?
No. Scratches can transmit rabies, so immediate washing and medical assessment should never be delayed.
4. What should patients do when a government hospital has no vaccine?
Ask for immediate referral, call the rabies helpline and continue treatment at another authorised facility.
5. Is rabies curable after symptoms begin?
Rabies is almost always fatal after symptoms appear, making timely post-exposure treatment the safest protection.
